Clinical trial
Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress…
NCT01470703 · Assistance Publique - Hôpitaux de Paris, Other · Completed
Key facts
| NCT number | NCT01470703 |
|---|---|
| Title | Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome |
| Official title | Extracorporeal Membrane Oxygenation(ECMO) for Severe Acute Respiratory Distress Syndrome (ARDS) |
| Acronym | EOLIA |
| Lead sponsor | Assistance Publique - Hôpitaux de Paris, Other |
| Collaborators | Maquet Cardiopulmonary GmbH Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Acute Respiratory Distress Syndrome (ARDS) |
| Intervention type | Device, Other |
| Interventions | ECMO (Quadrox®, Jostra®, Maquet®), conventional care |
| Enrollment | 249 |
| Start date | Dec 8, 2011 |
| Primary completion | Jul 1, 2017 |
| Completion | Sep 1, 2017 |
| First posted | Nov 11, 2011 |
| Last update posted | Dec 21, 2018 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: